AHA Research Grant Funding Opportunities

Implementation Science Award
Proposal deadline: Wednesday, February 5, 2025
For early and mid-career investigators proposing innovative implementation science studies that align with AHA’s mission and provide optimal approaches to improving public health. Implementation science uses evidence-based theories and frameworks to identify strategies that facilitate the uptake of evidence to improve health. Implementation science studies can use qualitative studies, mixed-methods, quasi-experimental designs, randomized controlled trials, and community-based participatory research.

AHA Predoctoral Fellowship
Deadline has passed for funding in 2025
Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.

AHA Postdoctoral Fellowship
Deadline has passed for funding in 2025
Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.

Established Investigator Award
Deadline has passed for funding in 2025
Supports established investigators in rapid career growth phase, with records of accomplishments and showing extraordinary promise. Candidates will have a demonstrated commitment to cardiovascular or cerebrovascular science disciplines that support the AHA’s mission, as indicated by funding and publication history and scientific accomplishments. Candidates should propose an innovative/novel research direction that challenges existing paradigms and employs novel concepts, approaches, or technologies.

Collaborative Sciences Award
Deadline has passed for funding in 2025
Fosters innovative collaborative approaches to research projects that propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co-principal investigators and their respective disciplines.

Planning Grant RFP through Healthcare by Food™ to be announced on January 6, 2025
Deadlines for proposals: March 11, 2025

The American Heart Association’s Health Care by Food™ initiative is building the evidence needed to show clinical and cost effectiveness so patients with acute or chronic disease or with risk factors for disease can access cost-effective food is medicine programs as a covered benefit through public and private health insurance.

A Request for Proposals (RFP) will be posted on January 6, 2025, for a planning grant opportunity. Funding will support development of a detailed trial protocol and grant on creating and testing ways in which food is medicine (FIM) interventions are efficacious for improved health outcomes. 

Funded investigators will receive salary and other support for one year as they work to optimize and finalize trial design, draft a grant proposal to a federal agency or other major funder, establish a research team, develop tools for data management and research oversight, and prepare other items needed to submit and conduct a rigorous trial of a FIM intervention. The primary deliverable is a competitive proposal for funding from a government agency or other major funder. 

See the Health Care by Food website for details.

Strategically Focused Research Network (SFRN) Cardiovascular Kidney Metabolic Syndrome: Heterogeneity in Women
Required pre-proposal deadline has passed

This initiative will support a collaborative network of researchers whose collective efforts will address critical questions and stimulate significant advances in our understanding of Cardiovascular Kidney Metabolic (CKM) Syndrome in women and the related contributing factors. CKM Syndrome is a health disorder due of connections among heart disease, kidney disease, diabetes and obesity. Health outcomes are poor and affect multiple organ systems, and the considerable heterogeneity seen in CKM is not well understood. Outcomes from the SFRN should facilitate improved approaches for both prevention and treatment of CKM.